Tetracycline
Tetracycline is a pharmaceutical drug with 33 clinical trials. Currently 4 active trials ongoing. Historical success rate of 90.9%.
Success Metrics
Based on 20 completed trials
Phase Distribution
Phase Distribution
3
Early Stage
3
Mid Stage
23
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
87.0%
20 of 23 finished
13.0%
3 ended early
4
trials recruiting
33
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Effect of Intraoperative Tetracycline on Postoperative Pain After Mandibular Molar Extraction
Sanitation, Water, and Instruction in Face-washing for Trachoma I/II
Tegoprazan-Based Therapies for H. Pylori Eradication: A Randomized Controlled Trial
Weekly Isotretinoin vs Tetracycline for Moderate Acne
Saccharomyces Boulardii Combined With Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Treatment
Clinical Trials (33)
Effect of Intraoperative Tetracycline on Postoperative Pain After Mandibular Molar Extraction
Sanitation, Water, and Instruction in Face-washing for Trachoma I/II
Tegoprazan-Based Therapies for H. Pylori Eradication: A Randomized Controlled Trial
Weekly Isotretinoin vs Tetracycline for Moderate Acne
Saccharomyces Boulardii Combined With Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Treatment
Rescue Therapy for Helicobacter Pylori Infection
Helicobacter Rescue Therapy With Vonorazon and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy
Tetracycline as a Prophylaxis for Rash in Patients With NSCLC Receiving Treatment With BIBW2992 (Afatinib)
Doxycycline for Helicobacter Pylori Rescue Treatment
Bismuth-containing Quadruple Therapy for Helicobacter Pylori Eradication
The Efficacy of the 7 Days Tailored Therapy as 2nd Rescue Therapy for Eradication of H. Pylori Infection
Helicobacter Rescue Therapy With High-dose Esomeprazole and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy
Susceptibility-Guided Therapy for Helicobacter Pylori Infection Treatment
Helicobacter Pylori Eradication and Follow-up
Tetracycline Versus Doxycycline for HP Rescue Therapy
Bismuth-containing Quadruple Therapy for Helicobacter Pylori Eradication: A Randomized Clinical Trial of 10 and 14 Days
Tailored Therapy for Helicobacter Pylori Treatment in Patients With Penicillin Allergy
Helicobacter Rescue Therapy With Berberine Plus Amoxicillin Quadruple Therapy Versus Tetracycline Plus Furazolidone Quadruple Therapy
Evaluate the PK of Multiple Oral Doses of Tegoprazan, Metronidazole, Tetracycline and Bismuth in Healthy Volunteers
Compare Sequential and Quadruple Therapy for the Eradication of Helicobacter Pylori in Korea
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 33